Analog of Somatostatin Vapreotide Exhibits Biological Effects in vitro via Interaction with Neurokinin-1 Receptor
- 5 July 2013
- journal article
- research article
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 20 (5) , 247-255
Abstract
Objectives: Vapreotide, a synthetic analog of somatostatin, has analgesic activity most likely mediated through the blockade of neurokinin-1 receptor (NK1R), the substance P (SP)-preferring receptor. The ability of vapreotide to interfere with other biological effects of SP has yet to be investigated. Methods: We studied the ability of vapreotide to antagonize NK1R in three different cell types: immortalized U373MG human astrocytoma cells, human monocyte-derived macrophages (MDM) and a human embryonic kidney cell line, HEK293. Both U373MG and MDM express endogenous NK1R while HEK293 cells, which normally do not express NK1R, are stably transformed to express human NK1R (HEK293-NK1R). Results: Vapreotide attenuates SP-triggered intracellular calcium increases and nuclear factor-κB activation in a dose-dependent manner. Vapreotide also inhibits SP-induced interleukin-8 and monocyte chemotactic protein-1 production in HEK293-NK1R and U373MG cell lines. Vapreotide inhibits HIV-1 infection of human MDM in vitro, an effect that is reversible by SP pretreatment. Conclusions: Our findings indicate that vapreotide has NK1R antagonist activity and may have a potential application as a therapeutic intervention in HIV-1 infection.Keywords
This publication has 56 references indexed in Scilit:
- Substance P–Neurokinin-1 receptor interaction upregulates monocyte tissue factorJournal of Neuroimmunology, 2012
- Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretroviralsAIDS, 2010
- Neurokinin‐1 receptor: functional significance in the immune system in reference to selected infections and inflammationAnnals of the New York Academy of Sciences, 2010
- Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent MechanismJournal of Biological Chemistry, 2009
- Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)Journal of Leukocyte Biology, 2008
- Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptorProceedings of the National Academy of Sciences, 2008
- Neurokinin-1 Receptor Antagonist (Aprepitant) Suppresses HIV-1 Infection of Microglia/MacrophagesJournal of Neuroimmune Pharmacology, 2008
- Role of calcium in substance P‐induced chemokine synthesis in mouse pancreatic acinar cellsBritish Journal of Pharmacology, 2008
- Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regionsJournal of Neuroscience Methods, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001